Oxford Cancer Biomarkers Competitors and Similar CompaniesClear all

Oxford Cancer Biomarkers's competitors and similar companies include C2i Genomics, Calviri, BioInvent and Diatech Pharmacogenetics.

	Oxford Cancer Biomarkers Oxford Cancer Biomarkers (OCB) is a company that develops and commercializes biomarker tests.	C2i Genomics C2i Genomics is a company that provides cloud-based cancer diagnostic services to pharmaceutical and diagnostic organizations.	Calviri Calviri is a company that develops diagnostic and therapeutic products, as well as vaccines aimed to prevent cancer.	BioInvent BioInvent focuses on the discovery and development of antibody-based drugs against cancer.	Diatech Pharmacogenetics Diatech Pharmacogenetics is a provider of molecular diagnostic tools for precision medicine.
Founding Date	Founding Date 2012	Founding Date 2019	Founding Date 2018	Founding Date 1997	Founding Date 1994
Type	Type Private	Type Private	Type Private	Type Public	Type Private
Tags	Tags Healthcare biotech medical diagnostics oncology pharma	Tags Healthcare medical diagnostics oncology pharma	Tags Healthcare biotech drug development medical diagnostics oncology pharma	Tags Healthcare biotech drug development medical diagnostics oncology pharma	Tags Healthcare biotech medical diagnostics oncology pharma
Locations	Locations Kilmacolm, GB HQ	Locations New York, US HQ Tirat Carmel, IL	Locations Phoenix, US HQ	Locations Lund, SE HQ	Locations Jesi, IT HQ
Employees	Employees 713% decrease	Employees 22	Employees 16	Employees 118	Employees 751% increase
Funding
Latest funding round	Latest funding round N/A	Latest funding round $ 100m (about 5 years ago)	Latest funding round $ 2.3m (about 6 years ago)	Latest funding round N/A	Latest funding round $ 1.9m (almost 11 years ago)
Total funding raised	Total funding raised N/A	Total funding raised $ 112m	Total funding raised $ 2.3m	Total funding raised N/A	Total funding raised $ 1.9m